1
|
Du S, Wu Y, Tao J, Shu L, Yan T, Xiao B, Lv S, Ye M, Gong Y, Zhu X, Hu P, Wu M. Development and Validation of Machine Learning Models for Outcome Prediction in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment. Ther Clin Risk Manag 2025; 21:293-307. [PMID: 40071129 PMCID: PMC11895686 DOI: 10.2147/tcrm.s504745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Accepted: 02/25/2025] [Indexed: 03/14/2025] Open
Abstract
Background Endovascular treatment (EVT) has been recommended as a superior modality for the treatment of intracranial aneurysm. However, there still exists a worse percentage of poor functional outcome in patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) undergoing EVT. Therefore, it is urgently needed to investigate the risk factors and develop a critical decision model in the subtype of such patients. Methods We extracted the target variables from an ongoing registry cohort study, PROSAH-MPC, which was conducted in multiple centers in China. We randomly assigned these patients to training and validation cohorts with a ratio of 7:3. Univariate and multivariate logistic regressions were performed to find the potential factors, and then nine machine learning models and a stack ensemble model were developed with optimized variables. The performance of these models was evaluated through several indicators, including area under the receiver operating characteristic curve (AUC-ROC). We further use Shapley Additive Explanations (SHAP) methods for the distribution of feature visualization based on the optimal models. Results A total of 226 eligible patients with poor-grade aSAH undergoing EVT were enrolled, while 89 (39.4%) has a poor 12-month outcome. Age (Adjusted OR [aOR], 1.08; 95% CI: 1.03-1.13; p = 0.002), subarachnoid hemorrhage volume (aOR, 1.02; 95% CI: 1.00-1.05; p = 0.033), World Federation of Neurosurgical Societies grade (WFNS) (aOR, 2.03; 95% CI: 1.05-3.93; p = 0.035), and Hunt-Hess grade (aOR, 2.36; 95% CI: 1.13-4.93; p = 0.022) were identified as the independent risk factors of the poor outcome. Then, the prediction models developed have revealed that LightGBM algorithm has a superior performance with an AUC-ROC value of 0.842 in the validation cohort, while the SHAP results showed that age is the most important risk factor affecting functional outcomes. Conclusion The LightGBM model holds immense potential in facilitating risk stratification for poor-grade aSAH patients undergoing endovascular treatment who are at risk of adverse outcomes, thereby enhancing clinical decision-making processes. Trial Registration PROSAH-MPC. NCT05738083. Registered 16 November 2022 - Retrospectively registered, https://clinicaltrials.gov/study/NCT05738083.
Collapse
Affiliation(s)
- Senlin Du
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, 330006, People’s Republic of China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, 330006, People’s Republic of China
- Institute of Neuroscience, Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Yanze Wu
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, 330006, People’s Republic of China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, 330006, People’s Republic of China
- Institute of Neuroscience, Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Jiarong Tao
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Lei Shu
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, 330006, People’s Republic of China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, 330006, People’s Republic of China
- Institute of Neuroscience, Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Tengfeng Yan
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, 330006, People’s Republic of China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, 330006, People’s Republic of China
- Institute of Neuroscience, Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Bing Xiao
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Shigang Lv
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Minhua Ye
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Yanyan Gong
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Xingen Zhu
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, 330006, People’s Republic of China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, 330006, People’s Republic of China
- Institute of Neuroscience, Nanchang University, Nanchang, 330006, People’s Republic of China
| | - Ping Hu
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
- Department of Neurosurgery, Panzhihua Central Hospital, The second Clinical Medical College of Panzhihua University, Panzhihua, 617067, People’s Republic of China
| | - Miaojing Wu
- Department of Neurosurgery, The second Affiliated Hospital, Jiangxi Medical College of Nanchang University, Nanchang, 330006, People’s Republic of China
| |
Collapse
|
2
|
Khaniyev T, Cekic E, Gecici NN, Can S, Ata N, Ulgu MM, Birinci S, Isikay AI, Bakir A, Arat A, Hanalioglu S. Predicting Mortality in Subarachnoid Hemorrhage Patients Using Big Data and Machine Learning: A Nationwide Study in Türkiye. J Clin Med 2025; 14:1144. [PMID: 40004675 PMCID: PMC11856828 DOI: 10.3390/jcm14041144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Revised: 01/22/2025] [Accepted: 01/24/2025] [Indexed: 02/27/2025] Open
Abstract
Background/Objective: Subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality rates, necessitating prognostic algorithms to guide decisions. Our study evaluates the use of machine learning (ML) models for predicting 1-month and 1-year mortality among SAH patients using national electronic health records (EHR) system. Methods: Retrospective cohort of 29,274 SAH patients, identified through national EHR system from January 2017 to December 2022, was analyzed, with mortality data obtained from central civil registration system in Türkiye. Variables included (n = 102) pre- (n = 65) and post-admission (n = 37) data, such as patient demographics, clinical presentation, comorbidities, laboratory results, and complications. We employed logistic regression (LR), decision trees (DTs), random forests (RFs), and artificial neural networks (ANN). Model performance was evaluated using area under the curve (AUC), average precision, and accuracy. Feature significance analysis was conducted using LR. Results: The average age was 56.23 ± 16.45 years (47.8% female). The overall mortality rate was 22.8% at 1 month and 33.3% at 1 year. One-month mortality increased from 20.9% to 24.57% (p < 0.001), and 1-year mortality rose from 30.85% to 35.55% (p < 0.001) in the post-COVID period compared to the pre-COVID period. For 1-month mortality prediction, the ANN, LR, RF, and DT models achieved AUCs of 0.946, 0.942, 0.931, and 0.916, with accuracies of 0.905, 0.901, 0.893, and 0.885, respectively. For 1-year mortality, the AUCs were 0.941, 0.927, 0.926, and 0.907, with accuracies of 0.884, 0.875, 0.861, and 0.851, respectively. Key predictors of mortality included age, cardiopulmonary arrest, abnormal laboratory results (such as abnormal glucose and lactate levels) at presentation, and pre-existing comorbidities. Incorporating post-admission features (n = 37) alongside pre-admission features (n = 65) improved model performance for both 1-month and 1-year mortality predictions, with average AUC improvements of 0.093 ± 0.011 and 0.089 ± 0.012, respectively. Conclusions: Our study demonstrates the effectiveness of ML models in predicting mortality in SAH patients using big data. LR models' robustness, interpretability, and feature significance analysis validate its importance. Including post-admission data significantly improved all models' performances. Our results demonstrate the utility of big data analytics in population-level health outcomes studies.
Collapse
Affiliation(s)
- Taghi Khaniyev
- Department of Industrial Engineering, Faculty of Engineering, Bilkent University, 06800 Ankara, Türkiye;
- National Magnetic Resonance Research Center (UMRAM), Bilkent University, 06800 Ankara, Türkiye
- Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Efecan Cekic
- Department of Neurosurgery, Faculty of Medicine, Hacettepe University, 06100 Ankara, Türkiye; (E.C.); (N.N.G.); (A.I.I.)
| | - Neslihan Nisa Gecici
- Department of Neurosurgery, Faculty of Medicine, Hacettepe University, 06100 Ankara, Türkiye; (E.C.); (N.N.G.); (A.I.I.)
- Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
| | - Sinem Can
- General Directorate of Health Information System, Republic of Türkiye Ministry of Health, 06800 Ankara, Türkiye; (S.C.); (N.A.); (M.M.U.)
| | - Naim Ata
- General Directorate of Health Information System, Republic of Türkiye Ministry of Health, 06800 Ankara, Türkiye; (S.C.); (N.A.); (M.M.U.)
| | - Mustafa Mahir Ulgu
- General Directorate of Health Information System, Republic of Türkiye Ministry of Health, 06800 Ankara, Türkiye; (S.C.); (N.A.); (M.M.U.)
| | - Suayip Birinci
- Republic of Türkiye Ministry of Health, 06800 Ankara, Türkiye;
| | - Ahmet Ilkay Isikay
- Department of Neurosurgery, Faculty of Medicine, Hacettepe University, 06100 Ankara, Türkiye; (E.C.); (N.N.G.); (A.I.I.)
| | - Abdurrahman Bakir
- Department of Neurosurgery, Dr. Abdurrahman Yurtaslan Oncology Research and Education Hospital, 06800 Ankara, Türkiye;
| | - Anil Arat
- Department of Radiology, Faculty of Medicine, Hacettepe University, 06230 Ankara, Türkiye;
- Department of Neurosurgery, School of Medicine, Yale University, New Haven, CT 06520, USA
| | - Sahin Hanalioglu
- Department of Neurosurgery, Faculty of Medicine, Hacettepe University, 06100 Ankara, Türkiye; (E.C.); (N.N.G.); (A.I.I.)
- Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
| |
Collapse
|
3
|
Zhang H, Zou P, Luo P, Jiang X. Machine Learning for the Early Prediction of Delayed Cerebral Ischemia in Patients With Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis. J Med Internet Res 2025; 27:e54121. [PMID: 39832368 PMCID: PMC11791451 DOI: 10.2196/54121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 10/14/2024] [Accepted: 11/26/2024] [Indexed: 01/22/2025] Open
Abstract
BACKGROUND Delayed cerebral ischemia (DCI) is a primary contributor to death after subarachnoid hemorrhage (SAH), with significant incidence. Therefore, early determination of the risk of DCI is an urgent need. Machine learning (ML) has received much attention in clinical practice. Recently, some studies have attempted to apply ML models for early noninvasive prediction of DCI. However, systematic evidence for its predictive accuracy is still lacking. OBJECTIVE The aim of this study was to synthesize the prediction accuracy of ML models for DCI to provide evidence for the development or updating of intelligent detection tools. METHODS PubMed, Cochrane, Embase, and Web of Science databases were systematically searched up to May 18, 2023. The risk of bias in the included studies was assessed using PROBAST (Prediction Model Risk of Bias Assessment Tool). During the analysis, we discussed the performance of different models in the training and validation sets. RESULTS We finally included 48 studies containing 16,294 patients with SAH and 71 ML models with logistic regression as the main model type. In the training set, the pooled concordance index (C index), sensitivity, and specificity of all the models were 0.786 (95% CI 0.737-0.835), 0.77 (95% CI 0.69-0.84), and 0.83 (95% CI 0.75-0.89), respectively, while those of the logistic regression models were 0.770 (95% CI 0.724-0.817), 0.75 (95% CI 0.67-0.82), and 0.71 (95% CI 0.63-0.78), respectively. In the validation set, the pooled C index, sensitivity, and specificity of all the models were 0.767 (95% CI 0.741-0.793), 0.66 (95% CI 0.53-0.77), and 0.78 (95% CI 0.71-0.84), respectively, while those of the logistic regression models were 0.757 (95% CI 0.715-0.800), 0.59 (95% CI 0.57-0.80), and 0.80 (95% CI 0.71-0.87), respectively. CONCLUSIONS ML models appear to have relatively desirable power for early noninvasive prediction of DCI after SAH. However, enhancing the prediction sensitivity of these models is challenging. Therefore, efficient, noninvasive, or minimally invasive low-cost predictors should be further explored in future studies to improve the prediction accuracy of ML models. TRIAL REGISTRATION PROSPERO (CRD42023438399); https://tinyurl.com/yfuuudde.
Collapse
Affiliation(s)
- Haofuzi Zhang
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Peng Zou
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Peng Luo
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Xiaofan Jiang
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| |
Collapse
|
4
|
Liu L, Jiang J, Wu L, Zeng DM, Yan C, Liang L, Shi J, Xie Q. Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study. PeerJ 2024; 12:e17164. [PMID: 38560467 PMCID: PMC10979740 DOI: 10.7717/peerj.17164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Accepted: 03/06/2024] [Indexed: 04/04/2024] Open
Abstract
Objective This study aimed to create a predictive model based on machine learning to identify the risk for tracheobronchial tuberculosis (TBTB) occurring alongside Mycoplasma pneumoniae pneumonia in pediatric patients. Methods Clinical data from 212 pediatric patients were examined in this retrospective analysis. This cohort included 42 individuals diagnosed with TBTB and Mycoplasma pneumoniae pneumonia (combined group) and 170 patients diagnosed with lobar pneumonia alone (pneumonia group). Three predictive models, namely XGBoost, decision tree, and logistic regression, were constructed, and their performances were assessed using the receiver's operating characteristic (ROC) curve, precision-recall curve (PR), and decision curve analysis (DCA). The dataset was divided into a 7:3 ratio to test the first and second groups, utilizing them to validate the XGBoost model and to construct the nomogram model. Results The XGBoost highlighted eight significant signatures, while the decision tree and logistic regression models identified six and five signatures, respectively. The ROC analysis revealed an area under the curve (AUC) of 0.996 for XGBoost, significantly outperforming the other models (p < 0.05). Similarly, the PR curve demonstrated the superior predictive capability of XGBoost. DCA further confirmed that XGBoost offered the highest AIC (43.226), the highest average net benefit (0.764), and the best model fit. Validation efforts confirmed the robustness of the findings, with the validation groups 1 and 2 showing ROC and PR curves with AUC of 0.997, indicating a high net benefit. The nomogram model was shown to possess significant clinical value. Conclusion Compared to machine learning approaches, the XGBoost model demonstrated superior predictive efficacy in identifying pediatric patients at risk of concurrent TBTB and Mycoplasma pneumoniae pneumonia. The model's identification of critical signatures provides valuable insights into the pathogenesis of these conditions.
Collapse
Affiliation(s)
- Lin Liu
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - Jie Jiang
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - Lei Wu
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - De miao Zeng
- Department of Joint Surgery, he Hong-he Affiliated Hospital of Kunming Medical University/The Southern Central Hospital of Yun-nan Province (The First People’s Hospital of Honghe State), Changsha, Hunan, China
| | - Can Yan
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - Linlong Liang
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - Jiayun Shi
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| | - Qifang Xie
- Department of Pediatrics, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China
| |
Collapse
|
5
|
Shu L, Yan H, Wu Y, Yan T, Yang L, Zhang S, Chen Z, Liao Q, Yang L, Xiao B, Ye M, Lv S, Wu M, Zhu X, Hu P. Explainable machine learning in outcome prediction of high-grade aneurysmal subarachnoid hemorrhage. Aging (Albany NY) 2024; 16:4654-4669. [PMID: 38431285 PMCID: PMC10968679 DOI: 10.18632/aging.205621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 01/29/2024] [Indexed: 03/05/2024]
Abstract
OBJECTIVE Accurate prognostic prediction in patients with high-grade aneruysmal subarachnoid hemorrhage (aSAH) is essential for personalized treatment. In this study, we developed an interpretable prognostic machine learning model for high-grade aSAH patients using SHapley Additive exPlanations (SHAP). METHODS A prospective registry cohort of high-grade aSAH patients was collected in one single-center hospital. The endpoint in our study is a 12-month follow-up outcome. The dataset was divided into training and validation sets in a 7:3 ratio. Machine learning algorithms, including Logistic regression model (LR), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost), were employed to develop a prognostic prediction model for high-grade aSAH. The optimal model was selected for SHAP analysis. RESULTS Among the 421 patients, 204 (48.5%) exhibited poor prognosis. The RF model demonstrated superior performance compared to LR (AUC = 0.850, 95% CI: 0.783-0.918), SVM (AUC = 0.862, 95% CI: 0.799-0.926), and XGBoost (AUC = 0.850, 95% CI: 0.783-0.917) with an AUC of 0.867 (95% CI: 0.806-0 .929). Primary prognostic features identified through SHAP analysis included higher World Federation of Neurosurgical Societies (WFNS) grade, higher modified Fisher score (mFS) and advanced age, were found to be associated with 12-month unfavorable outcome, while the treatment of coiling embolization for aSAH drove the prediction towards favorable prognosis. Additionally, the SHAP force plot visualized individual prognosis predictions. CONCLUSIONS This study demonstrated the potential of machine learning techniques in prognostic prediction for high-grade aSAH patients. The features identified through SHAP analysis enhance model interpretability and provide guidance for clinical decision-making.
Collapse
Affiliation(s)
- Lei Shu
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Hua Yan
- Department of Emergency, Affiliated Hospital of Panzhihua University, Panzhihua 617000, Sichuan, China
| | - Yanze Wu
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Tengfeng Yan
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Li Yang
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Si Zhang
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Zhihao Chen
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Qiuye Liao
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Lu Yang
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Bing Xiao
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Minhua Ye
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Shigang Lv
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Miaojing Wu
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Xingen Zhu
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| | - Ping Hu
- Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China
- Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, China
- Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, China
- Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, China
| |
Collapse
|
6
|
Wang P, Chen K, Han Y, Zhao M, Abiyasi N, Peng H, Yan S, Shang J, Shang N, Meng W. Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patients. Future Oncol 2023; 19:1613-1626. [PMID: 37377070 DOI: 10.2217/fon-2022-1025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/29/2023] Open
Abstract
Background: We explored whether a model based on contrast-enhanced computed tomography radiomics features and clinicopathological factors can evaluate preoperative lymphovascular invasion (LVI) in patients with gastric cancer (GC) with Lauren classification. Methods: Based on clinical and radiomic characteristics, we established three models: Clinical + Arterial phase_Radcore, Clinical + Venous phase_Radcore and a combined model. The relationship between Lauren classification and LVI was analyzed using a histogram. Results: We retrospectively analyzed 495 patients with GC. The areas under the curve of the combined model were 0.8629 and 0.8343 in the training and testing datasets, respectively. The combined model showed a superior performance to the other models. Conclusion: CECT-based radiomics models can effectively predict preoperative LVI in GC patients with Lauren classification.
Collapse
Affiliation(s)
- Ping Wang
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Kaige Chen
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Ying Han
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Min Zhao
- Pharmaceutical Diagnostics, GE Healthcare, Beijing, China, 1#Tongji South Road, Daxing District, Beijing, 100176, China
| | - Nanding Abiyasi
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Haiyong Peng
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Shaolei Yan
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Jiming Shang
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Naijian Shang
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| | - Wei Meng
- Radiology Department, Harbin Medical University, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjiang, 150081, China
| |
Collapse
|
7
|
Peiyuan G, Xuhua H, Ganlin G, Xu Y, Zining L, Jiachao H, Bin Y, Guiying W. Construction and validation of a nomogram model for predicting the overall survival of colorectal cancer patients. BMC Surg 2023; 23:182. [PMID: 37386397 DOI: 10.1186/s12893-023-02018-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Accepted: 04/26/2023] [Indexed: 07/01/2023] Open
Abstract
BACKGROUND Colorectal cancer (CRC) is a frequent cancer worldwide with varied survival outcomes. OBJECTIVE We aimed to develop a nomogram model to predict the overall survival (OS) of CRC patients after surgery. DESIGN This is a retrospective study. SETTING This study was conducted from 2015 to 2016 in a single tertiary center for CRC. PATIENTS CRC patients who underwent surgery between 2015 and 2016 were enrolled and randomly assigned into the training (n = 480) and validation (n = 206) groups. The risk score of each subject was calculated based on the nomogram. All participants were categorized into two subgroups according to the median value of the score. MAIN OUTCOME MEASURES The clinical characteristics of all patients were collected, significant prognostic variables were determined by univariate analysis. Least absolute shrinkage and selection operator (LASSO) regression was applied for variable selection. The tuning parameter (λ) for LASSO regression was determined by cross-validation. Independent prognostic variables determined by multivariable analysis were used to establish the nomogram. The predictive capacity of the model was assessed by risk group stratification. RESULTS Infiltration depth, macroscopic classification, BRAF, carbohydrate antigen 19 - 9 (CA-199) levels, N stage, M stage, TNM stage, carcinoembryonic antigen levels, number of positive lymph nodes, vascular tumor thrombus, and lymph node metastasis were independent prognostic factors. The nomogram established based on these factors exhibited good discriminatory capacity. The concordance indices for the training and validation groups were 0.796 and 0.786, respectively. The calibration curve suggested favorable agreement between predictions and observations. Moreover, the OS of different risk subgroups was significantly different. LIMITATIONS The limitations of this work included small sample size and single-center design. Also, some prognostic factors could not be included due to the retrospective design. CONCLUSIONS A prognostic nomogram for predicting the OS of CRC patients after surgery was developed, which might be helpful for evaluating the prognosis of CRC patients.
Collapse
Affiliation(s)
- Guo Peiyuan
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China
| | - Hu Xuhua
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China
| | - Guo Ganlin
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China
| | - Yin Xu
- The Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, NO.139, Ziqiang Road, Shijiazhuang, Hebei Province, PR China
| | - Liu Zining
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China
| | - Han Jiachao
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China
| | - Yu Bin
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China.
| | - Wang Guiying
- The Second General Surgery, The Fourth Hospital of Hebei Medical University, NO.12, JianKang Road, Shijiazhuang, Hebei Province, PR China.
- The Department of General Surgery, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, Hebei Province, PR China.
| |
Collapse
|
8
|
Zhang N, Fan K, Ji H, Ma X, Wu J, Huang Y, Wang X, Gui R, Chen B, Zhang H, Zhang Z, Zhang X, Gong Z, Wang Y. Identification of risk factors for infection after mitral valve surgery through machine learning approaches. Front Cardiovasc Med 2023; 10:1050698. [PMID: 37383697 PMCID: PMC10294678 DOI: 10.3389/fcvm.2023.1050698] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Accepted: 05/31/2023] [Indexed: 06/30/2023] Open
Abstract
Background Selecting features related to postoperative infection following cardiac surgery was highly valuable for effective intervention. We used machine learning methods to identify critical perioperative infection-related variables after mitral valve surgery and construct a prediction model. Methods Participants comprised 1223 patients who underwent cardiac valvular surgery at eight large centers in China. The ninety-one demographic and perioperative parameters were collected. Random forest (RF) and least absolute shrinkage and selection operator (LASSO) techniques were used to identify postoperative infection-related variables; the Venn diagram determined overlapping variables. The following ML methods: random forest (RF), extreme gradient boosting (XGBoost), Support Vector Machine (SVM), Gradient Boosting Decision Tree (GBDT), AdaBoost, Naive Bayesian (NB), Logistic Regression (LogicR), Neural Networks (nnet) and artificial neural network (ANN) were developed to construct the models. We constructed receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) was calculated to evaluate model performance. Results We identified 47 and 35 variables with RF and LASSO, respectively. Twenty-one overlapping variables were finally selected for model construction: age, weight, hospital stay, total red blood cell (RBC) and total fresh frozen plasma (FFP) transfusions, New York Heart Association (NYHA) class, preoperative creatinine, left ventricular ejection fraction (LVEF), RBC count, platelet (PLT) count, prothrombin time, intraoperative autologous blood, total output, total input, aortic cross-clamp (ACC) time, postoperative white blood cell (WBC) count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), PLT count, hemoglobin (Hb), and LVEF. The prediction models for infection after mitral valve surgery were established based on these variables, and they all showed excellent discrimination performance in the test set (AUC > 0.79). Conclusions Key features selected by machine learning methods can accurately predict infection after mitral valve surgery, guiding physicians in taking appropriate preventive measures and diminishing the infection risk.
Collapse
Affiliation(s)
- Ningjie Zhang
- Department of Blood Transfusion, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Kexin Fan
- Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China
| | - Hongwen Ji
- Department of Anesthesiology, Fuwai Hospital National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| | - Xianjun Ma
- Department of Blood Transfusion, Qilu Hospital of Shandong University, Jinan, China
| | - Jingyi Wu
- Department of Transfusion, Xiamen Cardiovascular Hospital Xiamen University, Xiamen, China
| | - Yuanshuai Huang
- Department of Transfusion, The Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Xinhua Wang
- Department of Transfusion, Beijing Aerospace General Hospital, Beijing, China
| | - Rong Gui
- Department of Transfusion, The Third Xiangya Hospital, Central South University, Changsha, China
| | - Bingyu Chen
- Department of Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, China
| | - Hui Zhang
- Department of Basic Medical Sciences, Changsha Medical University, Changsha, China
| | - Zugui Zhang
- Institute for Research on Equity and Community Health, Christiana Care Health System, Newark, DE, United States
| | - Xiufeng Zhang
- Department of Respiratory Medicine, Second Affiliated Hospital of Hainan Medical University, Haikou, China
| | - Zheng Gong
- Sino-Cellbiomed Institutes of Medical Cell & Pharmaceutical Proteins Qingdao University, Qingdao, Shandong, China
- Department of Basic Medicine, Xiangnan University, Chenzhou, China
| | - Yongjun Wang
- Department of Blood Transfusion, The Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
9
|
Fan MC, Li HT, Sun J, Guan D, Yang ZJ, Feng YG. Preoperative prognostic nutrition index can independently predict the 6-month prognosis of elderly patients undergoing neurosurgical clipping for aneurysmal subarachnoid hemorrhage. Neurosurg Rev 2023; 46:117. [PMID: 37165260 DOI: 10.1007/s10143-023-02021-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Revised: 03/16/2023] [Accepted: 05/01/2023] [Indexed: 05/12/2023]
Abstract
The number of elderly patients with aneurysmal subarachnoid hemorrhage (aSAH) is increasing annually. The prognostic nutritional index (PNI) is used as a novel and valuable prognostic marker for various neoplastic diseases and other critical illnesses. This study aimed to identify the short-term prognostic value of preoperative PNI in elderly patients who underwent neurosurgical clipping for aSAH. This retrospective study included elderly patients with aSAH who underwent neurosurgical clipping from January 2018 to December 2020. Clinical variables and 6-month outcomes were collected and compared. Epidemiological data and effect factors of prognosis were evaluated. Multivariate logistic regression and receiver operating characteristics (ROC) curve analyses were used to evaluate the predictive value of preoperative PNI. Multiple logistic regression was performed to establish a nomogram. A total of 124 elderly patients were enrolled. Multivariate logistic regression analysis showed that preoperative PNI (odds ratio (OR), 0.779; 95% confidence interval (CI), 0.689-0.881; P < 0.001), Hunt-Hess grade (OR, 3.291; 95%CI, 1.816-5.966; P < 0.001), and hydrocephalus (OR, 9.423; 95%CI, 2.696-32.935; P < 0.001) were significant predictors. The area under the ROC curve of PNI was 0.829 (95% CI, 0.755-0.903; P < 0.001) with a sensitivity and specificity of 68.4% and 83.3%, respectively, and the cutoff value was 46.36. Patients with preoperative PNI of < 46.36 had a significantly unfavorable 6-months prognosis (F = 40.768, P < 0.001). Preoperative PNI is independently correlated with the 6-month prognosis in elderly patients who undergo neurosurgical clipping for aSAH.
Collapse
Affiliation(s)
- Ming-Chao Fan
- Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, China
- Department of Neurosurgical Intensive Care Unit, the Affiliated Hospital of Qingdao University, Qingdao, China
| | - Huan-Ting Li
- Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, China
| | - Jian Sun
- Department of Neurosurgical Intensive Care Unit, the Affiliated Hospital of Qingdao University, Qingdao, China
| | - Dong Guan
- Department of Neurosurgery, Qingdao Hospital of Traditional Chinese Medicine (Qingdao Hiser Hospital), Qingdao, China
| | - Zheng-Jie Yang
- Department of Neurology, the Affiliated Hospital of Qingdao University, Qingdao, China
| | - Yu-Gong Feng
- Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, China.
| |
Collapse
|